PROCTER & GAMBLE HEALTH
Quarterly Results Analysis [Dec2023]
PROCTER & GAMBLE HEALTH Quarterly Results
Standalone | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 Audited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 Audited |
Mar2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹310 Cr | ₹305 Cr | ₹301 Cr | ₹321 Cr | ₹310 Cr | ₹298 Cr | ₹296 Cr | ₹268 Cr |
Expenses | ₹208 Cr | ₹216 Cr | ₹256 Cr | ₹241 Cr | ₹201 Cr | ₹207 Cr | ₹237 Cr | ₹199 Cr |
Operating Income | ₹102 Cr | ₹89 Cr | ₹45 Cr | ₹80 Cr | ₹109 Cr | ₹91 Cr | ₹59 Cr | ₹69 Cr |
Other Income | ₹5 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹7 Cr | ₹6 Cr | ₹7 Cr | ₹6 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr |
Profit Before Tax | ₹100 Cr | ₹88 Cr | ₹44 Cr | ₹79 Cr | ₹105 Cr | ₹87 Cr | ₹55 Cr | ₹65 Cr |
Profit After Tax | ₹72 Cr | ₹66 Cr | ₹30 Cr | ₹59 Cr | ₹77 Cr | ₹64 Cr | ₹41 Cr | ₹51 Cr |
EPS | ₹43.42 | ₹39.50 | ₹17.96 | ₹35.66 | ₹46.27 | ₹38.35 | ₹24.81 | ₹30.82 |
Industry Peers & Returns | 1W | 1M | 1Y |
PROCTER & GAMBLE HEALTH | -1.7% | -6% | 1.3% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
PROCTER & GAMBLE HEALTH Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 1.65 % |
Y-o-Y | 0.00 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹310 Cr | 1.65 | |
Sep2023 | ₹305 Cr | 1.25 | |
Jun2023 | ₹301 Cr | -6.15 | |
Mar2023 | ₹321 Cr | 3.53 | |
Dec2022 | ₹310 Cr | 4.17 | |
Sep2022 | ₹298 Cr | 0.56 | |
Jun2022 | ₹296 Cr | 10.48 | |
Mar2022 | ₹268 Cr | - |
PROCTER & GAMBLE HEALTH Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 14.65 % |
Y-o-Y | -6.62 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹102 Cr | 14.65 | |
Sep2023 | ₹89 Cr | 95.54 | |
Jun2023 | ₹45 Cr | -43.08 | |
Mar2023 | ₹80 Cr | -26.82 | |
Dec2022 | ₹109 Cr | 19.86 | |
Sep2022 | ₹91 Cr | 53.83 | |
Jun2022 | ₹59 Cr | -14.15 | |
Mar2022 | ₹69 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 12.76 % |
Y-o-Y | -6.63 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 32.79% | 12.76 | |
Sep2023 | 29.08% | 93.22 | |
Jun2023 | 15.05% | -39.36 | |
Mar2023 | 24.82% | -29.33 | |
Dec2022 | 35.12% | 15.07 | |
Sep2022 | 30.52% | 52.98 | |
Jun2022 | 19.95% | -22.31 | |
Mar2022 | 25.68% | - |
PROCTER & GAMBLE HEALTH Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 9.91 % |
Y-o-Y | -6.16 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹72 Cr | 9.91 | |
Sep2023 | ₹66 Cr | 119.89 | |
Jun2023 | ₹30 Cr | -49.62 | |
Mar2023 | ₹59 Cr | -22.93 | |
Dec2022 | ₹77 Cr | 20.64 | |
Sep2022 | ₹64 Cr | 54.55 | |
Jun2022 | ₹41 Cr | -19.49 | |
Mar2022 | ₹51 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 8.14 % |
Y-o-Y | -6.17 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 23.25 % | 8.14 | |
Sep2023 | 21.5 % | 117.17 | |
Jun2023 | 9.9 % | -46.31 | |
Mar2023 | 18.44 % | -25.59 | |
Dec2022 | 24.78 % | 15.85 | |
Sep2022 | 21.39 % | 53.66 | |
Jun2022 | 13.92 % | -27.12 | |
Mar2022 | 19.1 % | - |
PROCTER & GAMBLE HEALTH Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 9.92 % |
Y-o-Y | -6.16 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹43.42 | 9.92 | |
Sep2023 | ₹39.5 | 119.93 | |
Jun2023 | ₹17.96 | -49.64 | |
Mar2023 | ₹35.66 | -22.93 | |
Dec2022 | ₹46.27 | 20.65 | |
Sep2022 | ₹38.35 | 54.57 | |
Jun2022 | ₹24.81 | -19.50 | |
Mar2022 | ₹30.82 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD